MARSHALL PROTOCOL. “These include a medication called Olmesartan medoxomil (or Benicar in the US), which binds to and activates the vitamin D receptor by displacing other forms of vitamin D and bacterial proteins from the receptor. This, in theory, enables the body to ‘turn on’ the innate immune system thus killing the pathogens and other co-infections.” As yet, formally untested.
https://lnkd.in/dTCkxDw